It is equally important to establish if the prospective AChE inhibitors identified in this study can be optimized for the treatment of diseases resulting from low levels of acetylcholine, such as Alzheimer's disease. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.